Recent general press releases & news

Citizens United for Research in Epilepsy Appoints Beth Lewin Dean as Chief Executive Officer

 [PRESSWIRE] CHICAGO, April 9, 2019 -- Citizens United for Research in Epilepsy (CURE) announced today the appointment of Beth Lewin Dean, MBA, MPA as the new Chief Executive Officer. Beth brings 17 years of extensive experience within the epilepsy field, which has been driven by her strong commitment to understanding the needs, aspirations and hopes of patients and their loved ones.  

Gemperle Farms Donates 8 Million Eggs Since 2000 to California's Central Valley Charities

[PRESSWIRE] TURLOCK, Calif., April 9, 2019 -- This week Gemperle Farms topped the 8 million mark for eggs donated to local charities since the year 2000. Each week thousands of Gemperle eggs go to lunch programs, local nonprofits, food banks, and food pantries. 

Graduation Fashion Show 2019/ 2020 at Dar Al Hekma under the patronage of Princess Noura Bint Faisal Al Saud

[PRESSWIRE] Saudi Arabia - 03 April, 2019 -- The Fashion Design Department, under the School of Design and Architecture at Dar Al-Hekma University, is proud to announce an upcoming female-only fashion show that will take place on April 12, 2019 at the Lexus Show Room on Medina Road, Jeddah, KSA, followed by an exhibition that will be open to the public on April 13, 2019. The Fashion Show event, called “Cultivation” will be showcasing the Fashion collections of the graduates of 2018-2019.

From Coffin Ships to Crowdfunding - Ending The Great Hunger Taboo

[PRESSWIRE] London, United Kingdom – 03 April 2019 -- A crowdfunding project is underway to fund the first feature-length movie to tell the whole story of the Irish Famine, including the role of the English Prime Minister, Lord John Russell and his infamous henchman Trevelyan.

BROWN + HUDSON DEVELOPS THE WORLD’S MOST SCIENTIFIC APPROACH TO BESPOKE TRAVEL PLANNING

[PRESSWIRE] London, United Kingdom – 02 April, 2019 -- To elevate bespoke luxury travel to new heights, bespoke travel company Brown + Hudson has developed a pioneering new science-based pre-travel interview process. Developed in conjunction with Michael Bond – writer, consultant on psychology and behaviour, and former editor at New Scientist Magazine, this new approach will bring more meaningful travel experiences to a discerning clientele.

GetInsured Abolishes Nearly $2 Million of Medical Debt in State of California

 [PRESSWIRE] MOUNTAIN VIEW, Calif., April 1, 2019 -- GetInsured, a leading provider of health insurance marketplace platforms, has abolished $1,856,771.28 of residents' medical debt in its home state of California, to help alleviate some of the severe financial hardship caused by unpaid and un-payable medical bills.

Princess Cruises Debuts Most Destination-Rich World Cruise Ever Offered

SANTA CLARITA, Calif., March 28, 2019 -- For more than two decades, Princess Cruises has been taking guests to iconic and off-the-beaten-path global destinations on annual World Cruises, offering the ultimate bucket-list vacation. The cruise line today announced its most robust 2021 World Cruise itinerary ever with more ports and countries than ever before.

MotoRefi Announces $4.7 Million Seed Raise

 [PRESSWIRE] ARLINGTON, Va., March 27, 2019 -- MotoRefi, an auto refinance startup that helps consumers save an average of $100 per month on their auto loan, today announced a $4.7 million seed raise led by Accomplice with participation from QED Investors and Motley Fool Ventures. Ryan Moore, co-founder of Accomplice, will join MotoRefi's board of directors.

Pet Market Upgrades to Brighter Future

 [PRESSWIRE] ROCKVILLE, Md., March 26, 2019 -- With humanization and premiumization now par for the course in the U.S. pet market, pet industry participants are thinking outside the box, with more and more of the avenues forged by e-commerce and IT, according to Packaged Facts' report U.S. Pet Market Outlook, 2019-2020.

Roivant Statement on Topline Results from EMPOWUR Phase 3 Study in Overactive Bladder

 [PRESSWIRE] NEW YORK and BASEL, Switzerland, March 19, 2019 -- Today Roivant subsidiary Urovant Sciences announced topline results from its Phase 3 EMPOWUR trial of vibegron in patients with overactive bladder. Vibegron achieved statistically significant improvements over placebo on both co-primary endpoints of the study as well as all seven key secondary endpoints. Over 30 million Americans over the age of 40 suffer from overactive bladder.